RETINITIS PIGMENTOSA (RP)

This study tests a new treatment called OpCT-001 for people with inherited eye diseases like retinitis pigmentosa and Usher syndrome, which cause vision loss. The treatment involves injecting special cells into the eye to replace damaged light-sensing cells. The study has two par…

This study tests a drug called ultevursen in 81 people with retinitis pigmentosa caused by a specific gene change (USH2A). The drug is injected into the eye and compared to a sham injection. The goal is to see if it can slow the loss of vision over two years. Participants must be…

This study looks at whether placing a small support ring (capsular tension ring) during cataract surgery helps keep the artificial lens more stable in people who also have retinitis pigmentosa, an eye disease that causes vision loss. Each of the 88 participants will get the ring …

This study tests a device called PRIMA, which is implanted in the eye to help restore central vision in people with inherited retinal diseases like Stargardt disease and retinitis pigmentosa. Five adults with severe vision loss will receive the implant and be monitored for improv…

This study looks at whether adding early nurse and psychologist support after a retinitis pigmentosa (RP) diagnosis helps patients feel better emotionally. RP is a rare, progressive eye disease, and the diagnosis can be very upsetting. Eighty newly diagnosed adults will be split …

This study looks at whether people with retinitis pigmentosa and similar eye diseases experience short-term improvements in vision after using a device that delivers mild electrical stimulation to the eye. The device is already approved in Europe to slow vision loss. Researchers …